191 related articles for article (PubMed ID: 31120154)
1. Immunophenotype of pediatric-onset mastocytosis does not correlate with clinical course.
Greenberger S; Landov H; Confino Y; Vaknine H; Avivi C; Baum S; Barzilai A
Pediatr Dermatol; 2019 Jul; 36(4):477-481. PubMed ID: 31120154
[TBL] [Abstract][Full Text] [Related]
2. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
[TBL] [Abstract][Full Text] [Related]
3. Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis.
Nwogbo OV; Fang H; Wang W; Xu J; Miranda RN; Bose P; Ok CY; Jorgensen JL; Medeiros LJ; Wang SA
Am J Clin Pathol; 2024 Jun; 161(6):598-608. PubMed ID: 38372648
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.
Morgado JM; Sánchez-Muñoz L; Teodósio CG; Jara-Acevedo M; Alvarez-Twose I; Matito A; Fernández-Nuñez E; García-Montero A; Orfao A; Escribano L
Mod Pathol; 2012 Apr; 25(4):516-21. PubMed ID: 22222639
[TBL] [Abstract][Full Text] [Related]
5. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
6. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow.
Jabbar KJ; Medeiros LJ; Wang SA; Miranda RN; Johnson MR; Verstovsek S; Jorgensen JL
Arch Pathol Lab Med; 2014 Sep; 138(9):1210-4. PubMed ID: 25171703
[TBL] [Abstract][Full Text] [Related]
8. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis.
Cherian S; McCullouch V; Miller V; Dougherty K; Fromm JR; Wood BL
Cytometry B Clin Cytom; 2016 Jul; 90(4):387-92. PubMed ID: 26525770
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous mastocytosis in children: a clinical analysis of 71 cases.
Kiszewski AE; Durán-Mckinster C; Orozco-Covarrubias L; Gutiérrez-Castrellón P; Ruiz-Maldonado R
J Eur Acad Dermatol Venereol; 2004 May; 18(3):285-90. PubMed ID: 15096137
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of paediatric mastocytosis: a review of 101 cases.
Lange M; Niedoszytko M; Renke J; Gleń J; Nedoszytko B
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):97-102. PubMed ID: 22126331
[TBL] [Abstract][Full Text] [Related]
12. Mastocytosis and related disorders.
Chiu A; Orazi A
Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.
Sotlar K; Cerny-Reiterer S; Petat-Dutter K; Hessel H; Berezowska S; Müllauer L; Valent P; Horny HP
Mod Pathol; 2011 Apr; 24(4):585-95. PubMed ID: 21186345
[TBL] [Abstract][Full Text] [Related]
16. Mastocytosis in children: clinicopathological study based on 35 cases.
Kiszewski AE; Alvarez-Mendoza A; Ríos-Barrera VA; Hernández-Pando R; Ruiz-Maldonado R
Histol Histopathol; 2007 May; 22(5):535-9. PubMed ID: 17330808
[TBL] [Abstract][Full Text] [Related]
17. A New Digital Method for Counting Mast Cells in Cutaneous Specific Lesions of Mastocytosis: A Series of Adult Cases of Mastocytosis With Clinical-Pathological Correlations.
Drabent P; Mitri R; Le Naour G; Hermine O; Rossignol J; Molina TJ; Barete S; Fraitag S
Am J Dermatopathol; 2021 Jan; 43(1):35-41. PubMed ID: 32568831
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.
Russano de Paiva Silva G; Tournier E; Sarian LO; Bulai-Livideanu C; Delsol G; Lamant L; Vassallo J; Brousset P; Laurent C
Medicine (Baltimore); 2018 May; 97(21):e10642. PubMed ID: 29794740
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.
Pardanani A; Kimlinger T; Reeder T; Li CY; Tefferi A
Leuk Res; 2004 Aug; 28(8):777-83. PubMed ID: 15203275
[TBL] [Abstract][Full Text] [Related]
20. Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children.
Hermans MAW; Pasmans SGMA; Arends NJT; van den Bosch TPP; van Daele PLA; van Doorn MBA; Huisman EJ; Mooyaart AL; Damman J
Clin Exp Dermatol; 2022 Sep; 47(9):1694-1702. PubMed ID: 35596520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]